So far, therapeutic agents against IL‐6, IL‐6 receptor (IL‐6R), IL-6-sIL-6R complex, or IL-6 downstream signal transducers have been developed, and determined to be effective in the intervention of inflammatory diseases and cancers. This evidence concerns the gene IL6 and cancer.